While serum PTHrP is a useful biomarker for diagnosing and monitoring HHM in cancer patients, its levels can vary depending on the type and stage of the cancer. Therefore, it is often used in conjunction with other diagnostic tools and clinical assessments to provide a comprehensive understanding of the patient’s condition.
